Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 1;14(1):5060.
doi: 10.1038/s41598-024-55548-x.

Sensitivity of lateral flow technique for diagnosis of canine parvovirus

M S Abousenna  1 , R H Sayed  2 , Shaimaa A E  2 , F A Shasha  2 , Sara E A El Sawy  2 , D M Darwish  2
Affiliations

Sensitivity of lateral flow technique for diagnosis of canine parvovirus

M S Abousenna et al. Sci Rep. .

Abstract

In this study, we devised a nanogold lateral flow immunoassay (LFA-CPV antigen test) for detecting canine parvovirus (CPV) in living attenuated CPV vaccines. We conducted instrumental characterization of the prepared nanogold particles and the developed LFA-CPV antigen test was rigorously evaluated for its performance verification including limit of detection, sensitivity, specificity, selectivity and accuracy. The LFA-CPV antigen test demonstrated strong performance when assessed against qPCR using different batches of live attenuated CPV vaccines, indicated a sensitivity of 96.4%, specificity of 88.2%, and an overall accuracy of 95%. These results suggest that the developed LFA-CPV antigen test could serve as a viable alternative for evaluation live attenuated CPV vaccines, and provide it as a point of care test for CPV diagnosis, offering a potential substitute for traditional laboratory methods, particularly qPCR.

Keywords: Antigen testing; CPV; Canine parvovirus vaccine; Diagnostic testing; Gold nanoparticles; Immuno-chromatographic; Lateral flow assay; Sensitivity and specificity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The description of the lateral flow assay (LFA) using the prepared LFA strip reveals the inclusion of distinct components: a sample pad, conjugation pad, nitrocellulose membrane, test line, control line, and an absorption pad.
Figure 2
Figure 2
TEM images of prepared Au NPs with different scales (100 and 200 nm) and SAED patterns.
Figure 3
Figure 3
UV–Vis absorption spectra of the prepared Au NPs. The absorbance spectra were normalized at 300 nm.
Figure 4
Figure 4
(a) Linear range and equation for CPV using qPCR. (b) Limit of detection (LOD) of the prepared LFA-CPV antigen using serial dilutions of phosphate buffer saline (PBS) spiked with CPV.
See this image and copyright information in PMC

References

    1. Mylonakis ME, Kalli I, Rallis TS. Canine parvoviral enteritis: An update on the clinical diagnosis, treatment, and prevention. Vet. Med. 2016;7:91–100. - PMC - PubMed
    1. Abousenna MS, Amal AM, Aziz HMGA, Barghooth WM, Shafik NG. Using of rapid elisa as an alternative method for evaluation of canine parvo vaccines. J. Anim. Health Prod. 2020;8(1):8–12. doi: 10.17582/journal.jahp/2020/8.1.8.12. - DOI
    1. Nakamura M, Tohya Y, Miyazawa T, Mochizuki M, Phung HT, Nguyen NH, Huynh LM, Nguyen LT, Nguyen PN, Nguyen PV, Nguyen NP, Akashi HA. Novel antigenic variant of canine parvovirus from a Vietnamese dog. Arch. Virol. 2004;149:2261–2269. doi: 10.1007/s00705-004-0367-y. - DOI - PubMed
    1. Decaro N, Buonavoglia C. Canine parvovirus: A review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet. Microbiol. 2012;155(1):1–12. doi: 10.1016/j.vetmic.2011.09.007. - DOI - PMC - PubMed
    1. Miranda C, Thompson G. Canine parvovirus: The worldwide occurrence of antigenic variants. J. Gen. Virol. 2016;97(9):2043–2057. doi: 10.1099/jgv.0.000540. - DOI - PubMed

Substances